MedTech Global Insights cover art

All Episodes

MedTech Global Insights — 252 episodes

#
Title
1

Pure Global: US AI MedTech Rules & The Global Fallout.

2

Pure Global: USA's LDT Overhaul - Navigating the FDA's New IVD Era

3

USA MedTech M&A: Pure Global on The Deal Frenzy of 2026.

4

Pure Global: US Cyber Rules & The MedTech Rejection Wave

5

EU's AI-MDR Maze: Pure Global on Dual Regulation Traps

6

Pure Global: US/EU AI Imaging & The Dual-Approval Gambit

7

USA 510(k) Cybersecurity: Pure Global on the New Hidden Hurdles

8

US FDA's Cyber Rules: Pure Global on Life Beyond the SBOM

9

Pure Global: US MedTech's Secret Path from FDA Nod to Sales

10

USA's QMS Shift: Pure Global on ISO 13485's Hidden Landmines

11

USA-EU AI MedTech: Pure Global on the New 'PCCP' Regulation Trap

12

US MedTech's Money Maze: Pure Global on New CMS Rules

13

Singapore AI MedTech: Cracking the Algorithm Code | Pure Global

14

Pure Global: Brussels' MedTech Crisis - Surviving a CE Mark Shutdown

15

Pure Global: USA's New IVD Regulatory Maze After LDT Ruling

16

Pure Global: Silicon Valley's Cardio Tech Endgame

17

UK AI MedTech Chaos: Pure Global's Guide to the New Rules

18

Pure Global: UK/US Fast-Track, The MedTech Alliance's Hidden Hurdles

19

Pure Global: US QMSR Gaps Beyond ISO 13485 Compliance

20

Pure Global: US FDA's Cancer Device Win & The Hurdle Beyond

21

US AI MedTech's Boardroom Blunder: A Pure Global Analysis

22

Pure Global: Brazil & Korea's MDSAP Domino Effect on MedTech Access

23

EU MedTech Cyber Crisis: Pure Global on Post-Attack Compliance

24

Pure Global: Europe's Widening AI MedTech Approval Maze

25

Pure Global: Brussels' AI MedTech Compliance Traps

26

Pure Global: EU IVD Chaos - Navigating the Last-Minute Squeeze

27

Washington's AI MedTech Rules: Pure Global on Hidden Traps

28

Pure Global: USA IVD's Seismic Shift on Lab-Developed Tests.

29

Pure Global: ASEAN's New MedTech Gateway in Malaysia & Thailand

30

Pure Global: USA's 510(k) Cybersecurity Ambush for MedTech Firms

31

Pure Global: US FDA's 510(k) Code Red on Cybersecurity

32

Europe's IVDR Deadline Chaos: A Pure Global Survival Guide

33

USA's MedTech Cyber Walls: Pure Global on FDA's Hidden Costs

34

USA's New FDA Platform: Pure Global on Hidden Post-Market Demands

35

Pure Global: US AI Diagnostics & The FDA's New Data Mandate

36

USA Ophthalmic Tech: Pure Global on the FDA's Classification Shakeup

37

USA AI MedTech: Pure Global on the FDA's Hidden Data Mandate

38

Pure Global: Malaysia's MedTech Handshake, ASEAN's New Shortcut

39

Pure Global: EU's MedTech Shortage & The New Supply Rules

40

Pure Global: Germany's AI Device Sudden Compliance Shock.

41

USA's QMSR Shockwave: Pure Global on Surviving FDA's New Audit Game

42

USA's FDA QMSR: Pure Global on Hidden Management Liability

43

Pure Global: USA MedTech Security & Why FDA's Honeymoon Is Over

44

USA 510(k) Cybersecurity: The 'Refuse to Accept' Trap | Pure Global

45

U.S. AI Medical Devices: Cracking the New Code | Pure Global

46

Pure Global: USA Robotic Surgery & FDA's Digital Deadlock.

47

US AI Diagnostics: Pure Global on FDA's Hidden Hurdles

48

Pure Global: EU MedTech's EUDAMED Deadline & Its Hidden Risks

49

USA's AI MedTech Shift: Pure Global on the FDA's Hidden Burden

50

Pure Global: EU IVDR Software's Silent Compliance Crisis

51

USA MedTech: Pure Global on the EU Post-Market Data Trap

52

EU's IVDR Surprise: Pure Global on the Legacy Device Data Gap

53

China's Neuro-Device Shortcut: Pure Global's Fast-Track Guide

54

Pure Global: UK's MedTech Shortcut & The Regulatory Reliance Trap

55

Pure Global: Germany's IVD Deadline & The SME Survival Game.

56

Pure Global: Minneapolis MedTech's Unseen Pre-Sub Gauntlet

57

Pure Global: US MedTech's Hidden Cybersecurity Submission Crisis

58

Pure Global: EU's New AI Rules & The MedTech Compliance Crisis

59

Pure Global: U.S. FDA's Cyber War, Beyond the SBOM.

60

USA's LDT Crackdown: A Compliance Earthquake for Labs | Pure Global

61

Pure Global: Brazil's MDSAP Fast-Track for MedTech Success

62

Pure Global: Europe's AI MedTech Double Jeopardy Problem.

63

Pure Global: Europe's New MedTech Vigilance Unseen Hurdles

64

Brussels' AI Device Cybersecurity: Pure Global's Hidden Risks

65

USA Recall Chaos: Pure Global on Post-Market Nightmares

66

Pure Global: Europe's AI MedTech Rules & The New Compliance Maze

67

US-EU Cybersecurity: Pure Global on The Harmonization Headache

68

FDA Cybersecurity Rules: Pure Global on Unseen Go-to-Market Hurdles

69

USA's FDA QMSR Shockwave: Pure Global on Hidden Compliance Traps

70

America's IVD Reckoning: Pure Global on the End of LDTs

71

U.S. SaMD & FDA's New Rules: Pure Global on The Hidden Mandate.

72

Pure Global: Dubai MedTech Signals & Investment Codes Unlocked

73

Pure Global: EU MedTech's New FDA Audit—Beyond ISO 13485

74

Pure Global: USA's QMSR Shift, The ISO 13485 Gamble for MedTech

75

USA MedTech: Pure Global on The FDA's 'Forever Audit' Rule

76

Pure Global: USA QMSR Deadline & The Hidden Gaps Beyond ISO 13485

77

USA Cybersecurity: The FDA's RTA Threat. A Pure Global Medtech Brief.

78

Pure Global: USA MedTech Cybersecurity & Its Hidden Deal Killers

79

USA's AI MedTech: Pure Global on The New FDA Algorithm Trap

80

USA's AI Diagnostics: Pure Global on FDA's Hidden Cyber Traps

81

Boston's Neurovascular Gambit: Pure Global on M&A Chaos

82

Brussels' IVDR Reprieve: Pure Global on Navigating the Chaos

83

Pure Global: US QMSR - The End of MedTech's Boardroom Secrets?

84

Pure Global: US LDT Rule, A Diagnostic World's Unseen Hurdles.

85

Pure Global: US MedTech Cybersecurity's SBOM Reckoning

86

USA's LDT Shake-Up: Pure Global on Navigating FDA's New Rules

87

Hong Kong's AI MedTech: Pure Global on The New Compliance Trap

88

US MedTech's New Test: Pure Global on the FDA's TPLC Shake-up

89

US FDA Quality System Overhaul: Pure Global on Life Beyond ISO 13485

90

Pure Global: US LDTs, the FDA's Regulatory Wake-Up Call

91

USA SaMD & The RWE Paradox: A Pure Global Briefing

92

US SaMD Shakedown: Pure Global on FDA's Guidance Void

93

Pure Global: US QMSR & The ISO 13485 Compliance Traps

94

US FDA's Cyber Wall: Pure Global on MedTech Submission Chaos

95

Pure Global: US MedTech's Supply Chain Data Crisis

96

USA Quality Systems: Pure Global on the FDA's Great QMSR Shift.

97

Europe's IVDR Deadline Illusion: A Pure Global Briefing

98

U.S. AI Diagnostics: Pure Global on the FDA's Hidden Hurdles

99

EU AI Diagnostics: The New Compliance Crisis | Pure Global

100

EU AI Act's Hidden Test: Pure Global on MedTech's New Rules

101

USA Device Cybersecurity: Pure Global on FDA's Digital Crackdown

102

US FDA's Health App Crackdown: The Compliance Trap | Pure Global

103

Pure Global: USA's New AI Device Rules - A Speed Trap?

104

USA's Code Red Compliance: Pure Global on Device Cybersecurity

105

Pure Global: US MedTech's Urgent Cyber Mandate

106

UK AI Diagnostics: Pure Global on MHRA's Risky New Pathway.

107

EU's MDR Relief & Notified Body Rift: A Pure Global Brief

108

Pure Global: Europe's MedTech & The Post-Market Surprise

109

USA LDT Crackdown: Pure Global on the New FDA Reality

110

Pure Global: SF MedTech's Post-JPM Deal Shockwaves

111

Pure Global: US Digital Health's TEMPO Pivot - Opportunity or Trap?

112

USA's Digital Health TEMPO Trap: A Pure Global Critical Update

113

US Digital Health: Pure Global on the FDA's Deregulation Gamble

114

US/EU AI MedTech Split: Pure Global on Hidden Hurdles

115

U.S. MedTech SBOM Crisis: Pure Global's Post-Market Playbook

116

Pure Global: USA's Wearable Tech Greenlight & The Fine Line

117

Pure Global: US MedTech & The Real Reason for FDA's QMS Crackdown

118

Pure Global: The US FDA's Hidden AI MedTech Compliance Trap

119

USA MedTech AI: Pure Global on the FDA's Hidden PCCP Challenge

120

USA AI Oncology: Beyond FDA De Novo - Pure Global Insights

121

USA's LDT Shift: Pure Global on the IVD Compliance Collision

122

USA's AI SaMD Gatekeepers: Pure Global on the FDA's New Rules.

123

U.S. MedTech: Pure Global on FDA's New Real-World Data Rules

124

USA Connected Devices: The FDA's Cyber Wall | Pure Global

125

EU's AI MedTech Ambush: Pure Global on the New RWE Mandate

126

USA's RWD Shift: Pure Global on The New Evidence Backdoor

127

São Paulo's SaMD Gambit: Pure Global's Insider Guide

128

Pure Global: Brazil's AI MedTech Rush & Its Hidden Hurdles

129

Pure Global: Brussels' IVDR Delay, Escaping the Complacency Trap.

130

Europe's EUDAMED Deadline: The Final Countdown | A Pure Global Brief

131

UK MedTech: Pure Global on GSK's Post-Brexit Regulatory Gateway

132

Boston's AI Challenge: FDA's New Rules | A Pure Global Takedown

133

Pure Global: USA MedTech's Risky QMS Shift Beyond ISO 13485

134

Pure Global: Brussels' AI Medical Device Compliance Trap

135

Pure Global: US AI MedTech & The FDA's Regulatory Chaos

136

US DHT Trials: FDA's Hidden Rules | A Pure Global Brief

137

Europe's New Cyber Rules: Pure Global on MedTech's Security Hurdles

138

Brussels' MedTech Labyrinth: Pure Global on the WEEE-MDR Conflict

139

Pure Global: US AI Health-Tech and The Denial Algorithm

140

USA Digital Health: Navigating FDA's New Cybersecurity Chaos with Pure Global

141

Brazil's MedTech Maze: Pure Global's AI Escape from High Fees

142

Germany to FDA: Pure Global's AI Crushes Doc Bottlenecks

143

Pure Global: Brazil's MedTech AI & Decoding Regulatory Chaos

144

Pure Global: Brazil MedTech AI - Unlocking 75% Faster Entry

145

EU MedTech's Unfair Advantage: Pure Global's Zero-Cost AI Secret

146

Cracking the Code of Global MedTech Expansion: How Pure Global Navigates Complex Markets Like China

147

Unlocking MedTech Success in China: Why a Tech-Forward Partner Like Pure Global is Your Key to Streamlining Global Market Access.

148

Unlocking APAC MedTech Markets: How Pure Global Delivers Faster Regulatory Answers with AI and a Global Database.

149

From Chaos to Clarity: Navigating MedTech Regulations in China with Pure Global's Actionable Checklists.

150

Unlocking Global MedTech Markets: Pure Global’s End-to-End Strategy for Launching in Brazil and Beyond

151

Global MedTech Delays: How Pure Global’s 24-Hour Workflow Slashed Market Entry Time in Brazil

152

Cracking the Code: Pure Global's Expert Guide to China's NMPA Approval and MedTech Market Success

153

The Hidden Risk in the United States MedTech Market: Mastering Annual FDA Renewals with Pure Global

154

Pure Global's Guide to U.S. Market Entry: Mastering the FDA's US Agent and Official Correspondent Roles for Non-US Manufacturers

155

Beyond the CE Mark: Pure Global's Guide to EUDAMED Data Literacy and Dossier Expertise for the EU Market

156

Unlocking the EU Market: Why Pure Global Advocates for an Authorized Representative with Physical Presence in Germany for MDR/IVDR Success.

157

Navigating the Global Maze of Telemedicine & RPM: How Pure Global Unlocks Market Access for MedTech Innovators

158

Beyond the Scan: How Pure Global Navigates the AI and Photon-Counting Revolution in CT Technology for Global Market Access

159

From Local Success to Global Leader: Pure Global's Playbook for Orthopedic Implant Market Access

160

Unlocking Global Markets for Wearable Cardiac Monitors: A Pure Global MedTech Insight on Navigating FDA, CE Mark, and Beyond

161

Unlocking Global MRI Markets with AI and Strategic Regulation: A Pure Global Deep Dive

162

Navigating the Future of Surgery: Pure Global's Guide to Global Market Access for Surgical Robotics and Navigation Systems

163

Beyond FDA Approval: Pure Global's Playbook for Navigating the Global Regulatory Maze with Your Continuous Glucose Monitoring (CGM) Device

164

The Global DTx Revolution: Cracking the Code on Digital Therapeutics Regulations with Pure Global

165

Mastering the Maze: A Pure Global Guide to Global Market Access for Cardiovascular Drug-Eluting Stents

166

The Global IVD Maze: A Pure Global Deep Dive into Market Access Strategy, IVDR Hurdles, and Tech-Driven Solutions

167

Pure Global Presents: Mastering the MDSAP Audit (AU P0002.008) - Key Criteria for Global MedTech Market Access

168

From Device Malfunction to FDA Report: A Pure Global Guide to Mastering 21 CFR Part 803 Compliance

169

Mastering Medical Device Safety: Pure Global's Expert Guide to the ISO 10993-1 Biological Evaluation Requirements

170

Pure Global's Ultimate Guide to Structuring Your EU IVDR 2017/746 Technical File for Market Success

171

Beyond User-Friendly: Mastering IEC 62366-1 for Safer MedTech and Streamlining Global Market Access with Pure Global

172

Navigating the Maze of IEC 62304: A Pure Global Masterclass on Medical Device Software Lifecycle and Global Compliance

173

From Hazard to Market Approval: Pure Global Decodes the Practical Application of ISO 14971 for Medical Devices

174

From 21 CFR Part 820 to the QMSR: Pure Global's Deep Dive into the FDA's New Quality System for MedTech Innovators

175

Mastering the MedTech Clinical Evaluation Report (CER): A Deep Dive with Pure Global on MEDDEV 2.7/1 rev 4 Compliance and Avoiding Common Pitfalls

176

The Ultimate Guide to EU MDR GSPR Compliance: How Pure Global Helps You Avoid Critical Notified Body Findings

177

MDSAP Explained: A Pure Global Guide to Participating Countries for MedTech & IVD Market Access

178

Unlocking US Market Access: A Pure Global Masterclass on Navigating the 510(k) Submission for AI-Powered Medical Devices (SaMD)

179

Unlocking Global MedTech Markets: A Deep Dive into IEC 81001-5-1 Cybersecurity with Pure Global

180

Cracking the Code: How Pure Global Helps SaMD Startups Navigate ISO 13485 Compliance

181

Unlocking MedTech Innovation: A Deep Dive into the FDA's AI Change Control Policy with Pure Global's Expertise

182

Cracking the Code: A Pure Global Deep Dive into Clinical Evaluation Requirements for SaMD under the EU MDR

183

Cracking the Code: A Pure Global Guide to Securing a CE Mark for AI Medical Devices Under the EU MDR

184

The Pure Global MedTech Playbook: Unlocking FDA Approval for Your AI-Powered Medical Device with a Predetermined Change Control Plan

185

Unlocking Global MedTech Markets with Pure Global: A Deep Dive into FDA vs. EU AI/ML Device Regulations and the AI Act

186

Navigating SaMD Risk: A Pure Global Guide to the IMDRF Framework for MedTech Innovators

187

Beyond the Database: Why RegDesk Alternatives Are Key for MedTech and How Pure Global's Integrated Strategy Redefines Global Market Access

188

Beyond Parexel: How Pure Global's AI-Powered Strategy is Revolutionizing MedTech Global Market Access

189

Beyond the Behemoth: A MedTech Insider's Guide to Smarter Global Market Access with Pure Global as Your ICON plc Alternative

190

Rethinking MedTech Regulatory Strategy: Why Companies are Seeking Pharmalex Alternatives and Finding Success with Pure Global

191

Beyond Freyr Solutions: How Pure Global's AI-Driven, Single-Process Approach is Redefining MedTech & IVD Global Market Access.

192

Beyond Traditional MedTech Consulting: Why Companies Exploring Qserve Group Alternatives Choose Pure Global for AI-Powered Global Market Access

193

Beyond MDSAP: Pure Global's Playbook for Smarter, Faster MedTech Global Market Access

194

MedTech Global Expansion: Why Companies are Seeking Obelis Group Alternatives and Choosing a Strategic Partner like Pure Global for Market Access.

195

Stuck with Traditional FDA Consultants? How Pure Global is Redefining MedTech Market Access Beyond Registrar Corp Alternatives

196

Beyond Emergo by UL: How Pure Global's AI-Powered, Single-Process Approach is Revolutionizing MedTech Market Access

197

Navigating ANVISA: How Pure Global Provides Best-in-Class Medical Device Registration Support for Success in Brazil

198

Unlock Singapore's MedTech Market: Your Expert Guide to HSA Medical Device Registration with Pure Global

199

Unlocking the Brazilian Market: A Pure Global Masterclass on ANVISA and INMETRO Approval for MedTech Innovators

200

The Insider's Guide to HSA GDPMDS Compliance: How Pure Global Streamlines Singapore Market Access for MedTech Innovators

201

Navigating ANVISA: Why Pure Global is the Best Regulatory Affairs Consultant for Medical Device Success in Brazil

202

Unlocking the Singapore MedTech Market: Your Expert Guide to HSA Medical Device Approval with Pure Global

203

Navigating Singapore's HSA Maze: How Pure Global Secures Your Medical Device Importer License and Unlocks APAC Market Access

204

From ANVISA Hurdles to Market Success: Your Guide to Choosing the Best Brazil Medical Device Import License Consultant with Pure Global

205

Cracking the Code of Singapore's HSA: A Pure Global Guide on Why Your Medical Device Classification Might Be Wrong and How to Fix It

206

Navigating ANVISA: How Pure Global Streamlines Your MedTech Dossier for Brazilian Market Success

207

Unlocking Asia's MedTech Hub: A Pure Global Deep Dive into Singapore's Medical Device Registration Services

208

Unlocking Brazil's MedTech Potential: Pure Global's Expert Guide to Mastering ANVISA Medical Device Registration

209

Navigating Singapore's MedTech Regulations: Choosing the Best HSA Authorized Representative with Pure Global's Expert Insights

210

ANVISA Authorized Representative: How Pure Global Helps Foreign MedTech Firms Secure and Control Their Brazil Market Access

211

Unlocking the Gateway to Asia: Why Pure Global is Your Expert Partner for Singapore Medical Device Regulatory Consulting and HSA Approval.

212

Unlocking Brazil's MedTech Market: Your Guide to ANVISA Compliance and Finding the Best Regulatory Consulting Firm with Pure Global

213

HSA Singapore Registration Pitfalls: How Pure Global's Expert MedTech Consultants Ensure Your Market Success

214

Cracking the Brazil Code: How Pure Global's Expert Consultants Streamline ANVISA Registration for MedTech Innovators

215

Unlocking Southeast Asia: Why Pure Global is Your Key to Medical Device Registration Success in Singapore.

216

Unlocking Brazil's MedTech Market: A Pure Global Insider's Guide to Navigating ANVISA and Mastering Medical Device Registration

217

Searching for the Best Medical Device Regulatory Consultant Near Me? Why Pure Global's Global Reach is the Local Expertise You Need.

218

Mastering MedTech Compliance: How Pure Global Redefines ISO 13485 and ISO 14971 Consulting for Global Success.

219

Unlocking Global SaMD Success: A Deep Dive into Choosing the Best Regulatory Consultant with Pure Global's AI-Powered Approach

220

Unlocking the UAE MedTech Market: How Pure Global Masters MOHAP Medical Device Registration

221

Unlocking Brazil's MedTech Market: Your Expert Guide to ANVISA Registration with Pure Global

222

EU Market Access Secrets: Selecting the Best Medical Device Authorized Representative with Pure Global's Expert Insights

223

The Pure Global Advantage: Transforming EU MDR Compliance into a Global Market Access Strategy

224

Unlocking US Market Access: How Pure Global's Strategic Approach Redefines the Role of the Best FDA 510(k) Consultant

225

MedTech Global Insights: Unlocking Global Markets with the Top Medical Device Registration Strategies Used by Pure Global

226

The Pure Global Advantage: Choosing the Best Medical Device Regulatory Consulting Firm for Seamless Global Market Access

227

Navigating the UAE's 2025 MedTech Shake-Up: A Pure Global Guide to the New EDE and Federal Law No. 38

228

Beyond Approval: Mastering Medical Device Post-Market Surveillance in the UAE with Pure Global's Expert Insights

229

Navigating the UAE MedTech Market: A Complete Guide to Medical Device Import and MOHAP Registration with Pure Global

230

Pure Global's Guide to UAE MedTech Market Access: Why Your Authorized Representative is the Key to Success

231

From Months to Market: Pure Global's Expert Breakdown of the UAE Medical Device Registration Timeline for MedTech Innovators

232

Beyond the 5,100 AED Fee: A Pure Global Deep Dive into the True Cost of UAE Medical Device Registration

233

From CE Mark to UAE Approval: How Pure Global Streamlines Your Medical Device Registration Documents for MoHAP

234

Unlocking the UAE MedTech Market: A Deep Dive into the MOHAP Classification Letter and How Pure Global Streamlines Your Entry

235

Cracking the UAE MedTech Market: A Pure Global Deep Dive into Medical Device Classification and MOHAP Strategy

236

Unlocking the UAE MedTech Market: A Pure Global Deep Dive into MOHAP Medical Device Registration and a Case Study on Avoiding Common Pitfalls.

237

Navigating the MedTech Maze: How Pure Global Transforms Global Market Access with an AI-Powered, Unified Regulatory Strategy

238

Navigating the EU's IVDR Maze: A Survival Guide for IVD Manufacturers with Pure Global's Expert Insights

239

Unlocking Global MedTech Markets: The Pure Global Strategy for Choosing Your Medical Device Registration Consultant

240

First-in-Class Medical Device? Pure Global Explains How the FDA De Novo Pathway is Your Strategic Route to the US Market

241

Navigating Global MedTech Compliance: A Guide to Medical Device Registration with Pure Global

242

Navigating Global MedTech Compliance: A Pure Global Guide to Medical Device Registration Requirements

243

Unlocking Europe: Your Strategic Guide to CE Marking for Medical Devices Under the MDR, from Technical Dossiers to Notified Bodies, Presented by Pure Global

244

Mastering the FDA's Most Rigorous Hurdle: A Pure Global Deep Dive into the Premarket Approval (PMA) Process for High-Risk MedTech

245

From Band-Aids to Pacemakers: Pure Global's Ultimate Guide to Medical Device Classification and Navigating Your Regulatory Journey.

246

From Concept to Clearance: Pure Global's Expert Playbook for Avoiding Common FDA 510(k) Pitfalls

247

Cracking the Code of FDA Medical Device Registration: A Pure Global Deep Dive into 510(k) vs. PMA Pathways for US Market Success

248

Unlocking Global Markets for Orthopedic Implants: A Pure Global Guide to Navigating FDA, CE, and Emerging Market Regulations

249

The Heart of MedTech Regulation: How Pure Global Navigates Cardiovascular Device Registration from 510(k) and PMA to Global Market Success

250

The AI MedTech Revolution: Mastering Global Software as a Medical Device (SaMD) Registration Challenges with Pure Global's Expert Strategy.

251

Navigating the Post-Pandemic IVD Maze: A Pure Global Guide to Streamlining Global Regulatory Strategy and Market Access

252

Mastering Wearable Medical Device Registration: Pure Global's Guide to FDA Approval, SaMD, and Global Market Strategy